Evidence map›Paper›PMID 27917401›Full record

ReviewLaryngoscope investigative otolaryngology2016

AAO: Autoimmune and Autoinflammatory (Disease) in Otology: What is New in Immune-Mediated Hearing Loss.

Andrea Vambutas, Shresh Pathak

Open access · goldAbstract readReview
In one paragraph

Review in Laryngoscope investigative otolaryngology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 2 pooled it
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 2 syntheses or guidelines pooled it, 108 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Review
  6. Whole genome DNA methylation profiles define Meniere's disease subclusters.Journal of molecular medicine (Berlin, Germany) · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. A Selection Protocol to Identify Therapeutics to Target NLRP3-Associated Sensory Hearing Loss.Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology · 2024
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Sensorineural Hearing Loss in Sjögren's Syndrome.International journal of molecular sciences · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Andrea VambutasDepartment of Otolaryngology Hofstra-Northwell School of Medicine, Feinstein Institute for Medical Research Manhasset; Department of Molecular Medicine, Hofstra-Northwell School of Medicine Feinstein Institute for Medical Research Manhasset; Department of Otorhinolaryngology Albert Einstein College of Medicine Bronx New York U.S.A.
Shresh PathakDepartment of Otolaryngology Hofstra-Northwell School of Medicine, Feinstein Institute for Medical Research Manhasset; Department of OtorhinolaryngologyAlbert Einstein College of Medicine Bronx New York U.S.A.
Feinstein Institute for Medical Research · US

Funding

A phase I clinical trial of Anakinra for Steroid-Resistant AIEDR33DC011827 · NIDCD · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI VAMBUTAS, ANDREA · 2012 to 2015
$1.5M
NIDCD NIH HHS R33 DC011827
6 · The paper itself

Abstract

objectivesAutoinflammatory diseases are a family of immune-mediated, rare diseases, some of which, exhibit sensorineural hearing loss (SNHL), suggesting potentially similar mechanisms of molecular pathogenesis between autoinflammatory-mediated hearing loss and autoimmune inner ear disease (AIED) may exist. The purpose of this review is to compare the clinical features of autoimmune and autoinflammatory diseases that affect hearing, discuss the limitations of our knowledge, and highlight potential new disease mechanisms and therapeutics. DATA SOURCES: Pubmed Literature Review; Google Scholar Literature review. REVIEW

methodsA focused comparison of AIED with a number of autoinflammatory diseases that manifest with sensorineural hearing loss was performed. The pathogenesis of these diseases is reviewed in the context of the innate and adaptive immune system, cytokine expression and genetic polymorphisms.

resultsAIED, since first described by Cogan and Lehnhardt and first clinically characterized by McCabe, has remained an enigmatic disease, with limited advances in both new diagnostics and new therapeutics. Since the discovery of autoinflammatory diseases, a number of systemic autoimmune diseases have either been re-classed as autoinflammatory diseases or identified to have features of autoinflammatory disease.

conclusionAIED has clinical features of both autoimmune and autoinflammatory disease. It is critical that autoinflammatory diseases be correctly identified, as failure to do so may result in systemic amyloidosis and kidney damage.

Indexed as

autoimmuneAutoimmune inner ear diseaseautoinflammatoryhearing lossinterleukin‐1tumor necrosis factor

Identifiers

PMID27917401
PMCPMC5113311
OpenAlexW2528445454

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.